Epirium
San Diego, US · 3 known investors
Epirium Bio develops novel oral therapeutics targeting mitochondrial dysfunction and muscle diseases, particularly muscular dystrophy. The company's lead compound, EPM-01, is in Phase 1 clinical development for Becker muscular dystrophy.
Founders & leadership
PT
Pam TaubM.D., FACC, Founder
AM
Alan MaiselM.D., Founder
FV
Francisco VillarrealM.D., Ph.D., Founder
JT
Jonathan TaubFounder, Chief Executive Officer
GC
Guillermo CeballosM.D., Founding Scientist
RJ
Russell J. CoxPresident and CEO
Investors · 3
Frequently asked questions
- What does Epirium do?
- Epirium Bio develops novel oral therapeutics targeting mitochondrial dysfunction and muscle diseases, particularly muscular dystrophy. The company's lead compound, EPM-01, is in Phase 1 clinical development for Becker muscular dystrophy.
- Who founded Epirium?
- Epirium was founded by Pam Taub, Alan Maisel, Francisco Villarreal, Jonathan Taub, Guillermo Ceballos.
- Who are Epirium's investors?
- Epirium's investors include Bluebird Ventures, Broadview Ventures, Longitude Capital.
- Where is Epirium headquartered?
- Epirium is headquartered in San Diego, US.